v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating Activities:      
Net loss $ (1,450.9) $ (1,286.9) $ (462.6)
Adjustments to reconcile net loss to net cash generated by operating activities:      
Depreciation and amortization 561.2 696.1 786.3
Equity-based compensation 47.3 61.1 79.6
Deferred income taxes (183.3) (118.4) (147.5)
Asset impairments 1,217.6 1,119.6 13.7
Changes in assets and liabilities:      
Accounts receivable 461.7 (16.0) (59.6)
Inventories 391.3 (178.8) (359.8)
Prepaid expenses and other current assets 45.1 30.9 3.2
Accounts payable and other accrued liabilities (723.6) (43.2) 256.0
Other noncurrent assets (27.4) 8.2 (45.5)
Other noncurrent liabilities 55.0 (88.8) 8.4
Other (104.1) 6.2 50.1
Net cash generated by operating activities 289.9 190.0 122.3
Investing Activities:      
Additions to property, plant and equipment (53.3) (101.3) (131.4)
Proceeds from sale of property, plant and equipment 71.2 0.1 13.1
Payments upon settlement of net investment hedge 0.0 0.0 (18.0)
Other 20.4 19.1 (0.5)
Net cash generated by (used in) investing activities 38.3 (82.1) (136.8)
Financing Activities:      
Long-term debt repaid (32.0) (365.0) (1,282.0)
Long-term debt repurchases (142.6) 0.0 0.0
Long-term debt proceeds 0.0 333.0 1,250.0
Debt issuance costs 0.0 (7.2) (12.0)
Debt extinguishment costs 0.0 0.0 (34.4)
Dividends paid on Series A convertible preferred stock 0.0 (14.9) (43.0)
Proceeds from the issuance of common shares under equity-based compensation plans 0.0 0.0 5.6
Tax withholding payments for vested equity-based compensation awards (9.1) (14.8) (26.4)
Other 2.0 3.9 2.7
Net cash used in financing activities (181.7) (65.0) (139.5)
Effect of exchange rate changes on cash and cash equivalents (0.8) (5.1) (7.6)
Change in cash and cash equivalents 145.7 37.8 (161.6)
Cash and cash equivalents at beginning of period 398.1 360.3 521.9
Cash and cash equivalents at end of period $ 543.8 $ 398.1 $ 360.3